Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Translational Stroke Research
Erschienen in: Translational Stroke Research 2/2024

16.03.2023 | Review

Obstructive Sleep Apnea and Stroke: Determining the Mechanisms Behind their Association and Treatment Options

verfasst von: Basma Mohamed, Keerthi Yarlagadda, Zachary Self, Alexandra Simon, Frank Rigueiro, Maryam Sohooli, Stephan Eisenschenk, Sylvain Doré

Erschienen in: Translational Stroke Research | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Sleep-disordered breathing (SDB) can be a sequela of stroke caused by vascular injury to vital respiratory centers, cerebral edema, and increased intracranial pressure of space-occupying lesions. Likewise, obstructive sleep apnea (OSA) contributes to increased stroke risk through local mechanisms such as impaired ischemic cerebrovascular response and systemic effects such as promoting atherosclerosis, hypercoagulability, cardiac arrhythmias, vascular-endothelial dysfunction, and metabolic syndrome. The impact of OSA on stroke outcomes has been established, yet it receives less attention in national guidelines on stroke management than hyperglycemia and blood pressure dysregulation. Furthermore, whether untreated OSA worsens stroke outcomes is not well-described in the literature. This scoping review provides an updated investigation of the correlation between OSA and stroke, including inter-relational pathophysiology. This review also highlights the importance of OSA treatment and its role in stroke outcomes. Knowledge of pathophysiology, the inter-relationship between these common disorders, and the impact of OSA therapy on outcomes affect the clinical management of patients with acute ischemic stroke. In addition, understanding the relationship between stroke outcomes and pre-existing OSA will allow clinicians to predict outcomes while treating acute stroke.
Literatur
1.
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146-603.PubMedPubMedCentralCrossRef
2.
Khan MZ, Singh P. Anesthesia for endovascular therapy for acute ischemic stroke in adults. StatPearls. Treasure Island (FL): StatPearls Publishing, 2022.
3.
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006–14.PubMedPubMedCentralCrossRef
4.
5.
Burman D. Sleep disorders: sleep-related breathing disorders. FP Essent. 2017;460:11–21.PubMed
6.
Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146:1387–94.PubMedCrossRef
7.
Malhotra A, Ayappa I, Ayas N, Collop N, Kirsch D, Mcardle N, et al. Metrics of sleep apnea severity: beyond the apnea-hypopnea index. Sleep. 2021;44.
8.
Medeiros CAM, de Bruin VMS, de Castro-Silva C, Araújo SMHA, Chaves Junior CM, de Bruin PFC. Neck circumference, a bedside clinical feature related to mortality of acute ischemic stroke. Rev Assoc Med Bras. 2011;57:559–64.PubMedCrossRef
9.
Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep. 1999;22:217–23.PubMedCrossRef
10.
Krystal AD, Edinger J, Wohlgemuth W, Marsh GR. Sleep in peri-menopausal and post-menopausal women. Sleep Med Rev. 1998;2:243–53.PubMedCrossRef
11.
Schmidt-Nowara WW, Coultas DB, Wiggins C, Skipper BE, Samet JM. Snoring in a Hispanic-American population. Risk factors and association with hypertension and other morbidity. Arch Intern Med. 1990;150:597–601.PubMedCrossRef
12.
Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Rein J, Vela-Bueno A, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med. 2001;163:608–13.PubMedCrossRef
13.
D’Ambrosio C, Stachenfeld NS, Pisani M, Mohsenin V. Sleep, breathing, and menopause: the effect of fluctuating estrogen and progesterone on sleep and breathing in women. Gend Med. 2005;2:238–45.PubMedCrossRef
14.
Sigurðardóttir ES, Gislason T, Benediktsdottir B, Hustad S, Dadvand P, Demoly P, et al. Female sex hormones and symptoms of obstructive sleep apnea in European women of a population-based cohort. PLoS ONE. 2022;17:e0269569.PubMedPubMedCentralCrossRef
15.
Waldron I. What do we know about causes of sex differences in mortality? A review of the literature. Popul Bull UN. 1985;59–76.
16.
Leech JA, Onal E, Dulberg C, Lopata MA. A comparison of men and women with occlusive sleep apnea syndrome. Chest. 1988;94:983–8.PubMedCrossRef
17.
Ware JC, McBrayer RH, Scott JA. Influence of sex and age on duration and frequency of sleep apnea events. Sleep. 2000;23:165–70.PubMedCrossRef
18.
Bonsignore MR, Saaresranta T, Riha RL. Sex differences in obstructive sleep apnoea. Eur Respir Rev. 2019;28.
19.
Hayden LP, Hobbs BD, Busch R, Cho MH, Liu M, Lopes-Ramos CM, et al. X Chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association study. Res Sq. 2022. Accessed 6 Apr 2022.
20.
Glasgow A, Greene C. Epigenetic mechanisms underpinning sexual dimorphism in lung disease. Epigenomics. 2022;14:65–7.PubMedCrossRef
21.
22.
Cunningham CM, Li M, Ruffenach G, Doshi M, Aryan L, Hong J, et al. Y-Chromosome gene, Uty, protects against pulmonary hypertension by reducing proinflammatory chemokines. Am J Respir Crit Care Med. 2022;206:186–96.PubMedPubMedCentralCrossRef
23.
Predescu DN, Mokhlesi B, Predescu SA. The impact of sex chromosomes in the sexual dimorphism of pulmonary arterial hypertension. Am J Pathol. 2022;192:582–94.PubMedPubMedCentralCrossRef
24.
Gabbay IE, Lavie P. Age- and gender-related characteristics of obstructive sleep apnea. Sleep Breath. 2012;16:453–60.PubMedCrossRef
25.
Lim Y-H, Choi J, Kim KR, Shin J, Hwang KG, Ryu S, et al. Sex-specific characteristics of anthropometry in patients with obstructive sleep apnea: neck circumference and waist-hip ratio. Ann Otol Rhinol Laryngol. 2014;123:517–23.PubMedCrossRef
26.
Cizza G, de Jonge L, Piaggi P, Mattingly M, Zhao X, Lucassen E, et al. Neck circumference is a predictor of metabolic syndrome and obstructive sleep apnea in short-sleeping obese men and women. Metab Syndr Relat Disord. 2014;12:231–41.PubMedPubMedCentralCrossRef
27.
Kum RO, Ozcan M, Yılmaz YF, Gungor V, Yurtsever Kum N, Unal A. The relation of the obstruction site on Muller’s maneuver with BMI, neck circumference and PSG findings in OSAS. Indian J Otolaryngol Head Neck Surg. 2014;66:167–72.PubMedPubMedCentralCrossRef
28.
Hasan A, Uzma N, Swamy TLN, Shoba A, Kumar BS. Correlation of clinical profiles with obstructive sleep apnea and metabolic syndrome. Sleep Breath. 2012;16:111–6.PubMedCrossRef
29.
Shah RV, Abbasi SA, Heydari B, Farhad H, Dodson JA, Bakker JP, et al. Obesity and sleep apnea are independently associated with adverse left ventricular remodeling and clinical outcome in patients with atrial fibrillation and preserved ventricular function. Am Heart J. 2014;167:620–6.PubMedPubMedCentralCrossRef
30.
31.
Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004;291:2013–6.PubMedCrossRef
32.
Wetter DW, Young TB, Bidwell TR, Badr MS, Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med. 1994;154:2219–24.PubMedCrossRef
33.
34.
Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, et al. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev. 2017;34:70–81.PubMedCrossRef
35.
Peregrim I, Grešová S, Pallayová M, Fulton BL, Štimmelová J, Bačová I, et al. Does obstructive sleep apnea worsen during REM sleep? Physiol Res. 2013;62:569–75.PubMedCrossRef
36.
Carberry JC, Jordan AS, White DP, Wellman A, Eckert DJ. Upper airway collapsibility (pcrit) and pharyngeal dilator muscle activity are sleep stage dependent. Sleep. 2016;39:511–21.PubMedPubMedCentralCrossRef
37.
Skatrud JB, Dempsey JA, Badr S, Begle RL. Effect of airway impedance on CO2 retention and respiratory muscle activity during NREM sleep. J Appl Physiol. 1988;65:1676–85.PubMedCrossRef
38.
Rudnicka A, Pływaczewski R, Jończak L, Górecka D, Sliwiński P. Prevalence of stroke in patients with obstructive sleep apnoea. Pneumonol Alergol Pol. 2010;78:121–5.PubMed
39.
Eckert DJ, Younes MK. Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment. J Appl Physiol. 2014;116:302–13.PubMedCrossRef
40.
Hirotsu C, Betta M, Bernardi G, Marques-Vidal P, Vollenweider P, Waeber G, et al. Pulse wave amplitude drops during sleep: clinical significance and characteristics in a general population sample. Sleep. 2020;43:zsz322.PubMedPubMedCentralCrossRef
41.
Sunwoo J-S, Hwangbo Y, Kim W-J, Chu MK, Yun C-H, Yang KI. Prevalence, sleep characteristics, and comorbidities in a population at high risk for obstructive sleep apnea: A nationwide questionnaire study in South Korea. PLoS ONE. 2018;13:e0193549.PubMedPubMedCentralCrossRef
42.
Walia HK, Li H, Rueschman M, Bhatt DL, Patel SR, Quan SF, et al. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. J Clin Sleep Med. 2014;10:835–43.PubMedPubMedCentralCrossRef
43.
Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3:310–8.PubMedPubMedCentralCrossRef
44.
Hou H, Zhao Y, Yu W, Dong H, Xue X, Ding J, et al. Association of obstructive sleep apnea with hypertension: a systematic review and meta-analysis. J Glob Health. 2018;8:010405.PubMedPubMedCentralCrossRef
45.
Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49:565–71.PubMedCrossRef
46.
47.
Monahan K, Storfer-Isser A, Mehra R, Shahar E, Mittleman M, Rottman J, et al. Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol. 2009;54:1797–804.PubMedPubMedCentralCrossRef
48.
Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173:910–6.PubMedPubMedCentralCrossRef
49.
Mehra R, Stone KL, Varosy PD, Hoffman AR, Marcus GM, Blackwell T, et al. Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med. 2009;169:1147–55.PubMedPubMedCentralCrossRef
50.
Selim BJ, Koo BB, Qin L, Jeon S, Won C, Redeker NS, et al. The association between nocturnal cardiac arrhythmias and sleep-disordered breathing: the DREAM study. J Clin Sleep Med. 2016;12:829–37.PubMedPubMedCentralCrossRef
51.
Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study JAMA. 2000;283:1829–36.PubMed
52.
Appleton SL, Vakulin A, Martin SA, Lang CJ, Wittert GA, Taylor AW, et al. Hypertension is associated with undiagnosed OSA during rapid eye movement sleep. Chest. 2016;150:495–505.PubMedCrossRef
53.
Sjöström C, Lindberg E, Elmasry A, Hägg A, Svärdsudd K, Janson C. Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax. 2002;57:602–7.PubMedPubMedCentralCrossRef
54.
Sasaki N, Nagai M, Mizuno H, Kuwabara M, Hoshide S, Kario K. Associations between characteristics of obstructive sleep apnea and nocturnal blood pressure surge. Hypertension. 2018;72:1133–40.PubMedCrossRef
55.
Ruttanaumpawan P, Nopmaneejumruslers C, Logan AG, Lazarescu A, Qian I, Bradley TD. Association between refractory hypertension and obstructive sleep apnea. J Hypertens. 2009;27:1439–45.PubMedCrossRef
56.
Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589–94.PubMedCrossRef
57.
Johnson DA, Thomas SJ, Abdalla M, Guo N, Yano Y, Rueschman M, et al. Association between sleep apnea and blood pressure control among blacks. Circulation. 2019;139:1275–84.PubMedPubMedCentralCrossRef
58.
Naruse Y, Tada H, Satoh M, Yanagihara M, Tsuneoka H, Hirata Y, et al. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm. 2013;10:331–7.PubMedCrossRef
59.
Guillot M, Sforza E, Achour-Crawford E, Maudoux D, Saint-Martin M, Barthélémy J-C, et al. Association between severe obstructive sleep apnea and incident arterial hypertension in the older people population. Sleep Med. 2013;14:838–42.PubMedCrossRef
60.
Haas DC, Foster GL, Nieto FJ, Redline S, Resnick HE, Robbins JA, et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation. 2005;111:614–21.PubMedCrossRef
61.
Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19:2271–7.PubMedCrossRef
62.
Mokhlesi B, Finn LA, Hagen EW, Young T, Hla KM, Van Cauter E, et al. Obstructive sleep apnea during REM sleep and hypertension. results of the Wisconsin Sleep Cohort. Am J Respir Crit Care Med. 2014;190:1158–67.PubMedPubMedCentralCrossRef
63.
O’Connor GT, Caffo B, Newman AB, Quan SF, Rapoport DM, Redline S, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179:1159–64.PubMedPubMedCentralCrossRef
64.
Kapur VK, Resnick HE, Gottlieb DJ, Sleep Heart Health Study Group. Sleep disordered breathing and hypertension: does self-reported sleepiness modify the association? Sleep. 2008;31:1127–32.PubMedPubMedCentral
65.
Cano-Pumarega I, Barbé F, Esteban A, Martínez-Alonso M, Egea C, Durán-Cantolla J, et al. Sleep apnea and hypertension: are there sex differences? The Vitoria sleep cohort. Chest. 2017;152:742–50.PubMedCrossRef
66.
Gonçalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I, et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest. 2007;132:1858–62.PubMedCrossRef
67.
Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O’Connor GT, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;6:e1000132.PubMedPubMedCentralCrossRef
68.
Parra O, Arboix A, Montserrat JM, Quintó L, Bechich S, García-Eroles L. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J. 2004;24:267–72.PubMedCrossRef
69.
Shpilsky D, Erqou S, Patel SR, Kip KE, Ajala O, Aiyer A, et al. Association of obstructive sleep apnea with microvascular endothelial dysfunction and subclinical coronary artery disease in a community-based population. Vasc Med. 2018;23:331–9.PubMedCrossRef
70.
Won CH, Chun HJ, Chandra SM, Sarinas PS, Chitkara RK, Heidenreich PA. Severe obstructive sleep apnea increases mortality in patients with ischemic heart disease and myocardial injury. Sleep Breath. 2013;17:85–91.PubMedCrossRef
71.
Yeboah J, Redline S, Johnson C, Tracy R, Ouyang P, Blumenthal RS, et al. Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA. Atherosclerosis. 2011;219:963–8.PubMedPubMedCentralCrossRef
72.
Alex R, Manchikatla S, Machiraju K, Altuwaijri E, Watenpaugh DE, Zhang R, et al. Effect of apnea duration on apnea induced variations in cerebral blood flow velocity and arterial blood pressure. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:270–3.
73.
Anter E, Di Biase L, Contreras-Valdes FM, Gianni C, Mohanty S, Tschabrunn CM, et al. Atrial substrate and triggers of paroxysmal atrial fibrillation in patients with obstructive sleep apnea. Circ Arrhythm Electrophysiol. 2017;10:e005407.PubMedPubMedCentralCrossRef
74.
Bouloukaki I, Grote L, McNicholas WT, Hedner J, Verbraecken J, Parati G, et al. Mild obstructive sleep apnea increases hypertension risk, challenging traditional severity classification. J Clin Sleep Med. 2020;16:889–98.PubMedPubMedCentralCrossRef
75.
Cadby G, McArdle N, Briffa T, Hillman DR, Simpson L, Knuiman M, et al. Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort. Chest. 2015;148:945–52.PubMedCrossRef
76.
Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110:364–7.PubMedCrossRef
77.
Lloyd EE, Durgan DJ, Martini SR, Bryan RM. Pathological effects of obstructive apneas during the sleep cycle in an animal model of cerebral small vessel disease. Hypertension. 2015;66:913–7.PubMedCrossRef
78.
Mansukhani MP, Calvin AD, Kolla BP, Brown RD, Lipford MC, Somers VK, et al. The association between atrial fibrillation and stroke in patients with obstructive sleep apnea: a population-based case-control study. Sleep Med. 2013;14:243–6.PubMedPubMedCentralCrossRef
79.
Patel NJ, Wells QS, Huang S, Upender RP, Darbar D, Monahan K. Relation of obstructive sleep apnea and a common variant at chromosome 4q25 to atrial fibrillation. Am J Cardiol. 2017;119:1387–91.PubMedPubMedCentralCrossRef
80.
Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–84.PubMedCrossRef
81.
Priou P, Le Vaillant M, Meslier N, Paris A, Pigeanne T, Nguyen X-L, et al. Cumulative association of obstructive sleep apnea severity and short sleep duration with the risk for hypertension. PLoS ONE. 2014;9:e115666.ADSPubMedPubMedCentralCrossRef
82.
Tamisier R, Pépin JL, Rémy J, Baguet JP, Taylor JA, Weiss JW, et al. 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. Eur Respir J. 2011;37:119–28.PubMedCrossRef
83.
Wu Y, Hu G, Pan F, Liu J, Mo X, Xie Y, et al. Obstructive sleep apnea hypopnea syndrome was a risk factor for uncontrolled hypertension in adult snorers in South China. Clin Exp Hypertens. 2016;38:429–34.PubMedCrossRef
84.
Xu J, Ding N, Zhang X, Wang N, Sun B, Zhang R, et al. Nocturnal blood pressure fluctuation and associated influential factors in severe obstructive sleep apnea patients with hypertension. Sleep Breath. 2018;22:1–8.CrossRef
85.
Youssef I, Kamran H, Yacoub M, Patel N, Goulbourne C, Kumar S, et al. Obstructive sleep apnea as a risk factor for atrial fibrillation: a meta-analysis. J Sleep Disord Ther. 2018;7:1000282
86.
Swartz RH, Cayley ML, Lanctôt KL, Murray BJ, Cohen A, Thorpe KE, et al. The “DOC” screen: feasible and valid screening for depression, obstructive sleep apnea (OSA) and cognitive impairment in stroke prevention clinics. PLoS ONE. 2017;12:e0174451.PubMedPubMedCentralCrossRef
87.
Kepplinger J, Barlinn K, Albright KC, Schrempf W, Boehme AK, Pallesen L-P, et al. Early sleep apnea screening on a stroke unit is feasible in patients with acute cerebral ischemia. J Neurol. 2013;260:1343–50.PubMedCrossRef
88.
Sico JJ, Yaggi HK, Ofner S, Concato J, Austin C, Ferguson J, et al. Development, validation, and assessment of an ischemic stroke or transient ischemic attack-specific prediction tool for obstructive sleep apnea. J Stroke Cerebrovasc Dis. 2017;26:1745–54.PubMedPubMedCentralCrossRef
89.
Tan A, Yin JDC, Tan LWL, van Dam RM, Cheung YY, Lee C-H. Predicting obstructive sleep apnea using the STOP-Bang questionnaire in the general population. Sleep Med. 2016;27–28:66–71.PubMedCrossRef
90.
Chung F, Subramanyam R, Liao P, Sasaki E, Shapiro C, Sun Y. High STOP-Bang score indicates a high probability of obstructive sleep apnoea. Br J Anaesth. 2012;108:768–75.PubMedPubMedCentralCrossRef
91.
Boulos MI, Wan A, Im J, Elias S, Frankul F, Atalla M, et al. Identifying obstructive sleep apnea after stroke/TIA: evaluating four simple screening tools. Sleep Med. 2016;21:133–9.PubMedCrossRef
92.
Boulos MI, Colelli DR, Vaccarino SR, Kamra M, Murray BJ, Swartz RH. Using a modified version of the “STOP-BANG” questionnaire and nocturnal oxygen desaturation to predict obstructive sleep apnea after stroke or TIA. Sleep Med. 2019;56:177–83.PubMedCrossRef
93.
Katzan IL, Thompson NR, Uchino K, Foldvary-Schaefer N. A screening tool for obstructive sleep apnea in cerebrovascular patients. Sleep Med. 2016;21:70–6.PubMedCrossRef
94.
Amra B, Javani M, Soltaninejad F, Penzel T, Fietze I, Schoebel C, et al. Comparison of Berlin Questionnaire, STOP-Bang, and Epworth Sleepiness Scale for diagnosing obstructive sleep apnea in Persian patients. Int J Prev Med. 2018;9:28.PubMedPubMedCentralCrossRef
95.
Reeves SL, Brown DL, Chervin RD, Morgenstern LB, Smith MA, Lisabeth LD. Agreement between stroke patients and family members for ascertaining pre-stroke risk for sleep apnea. Sleep Med. 2014;15:121–4.PubMedCrossRef
96.
Sharma SK, Vasudev C, Sinha S, Banga A, Pandey RM, Handa KK. Validation of the modified Berlin questionnaire to identify patients at risk for the obstructive sleep apnoea syndrome. Indian J Med Res. 2006;124:281–90.PubMed
97.
Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131:485–91.PubMedCrossRef
98.
Gus M, Gonçalves SC, Martinez D, de Abreu Silva EO, Moreira LB, Fuchs SC, et al. Risk for obstructive sleep apnea by Berlin questionnaire, but not daytime sleepiness, is associated with resistant hypertension: a case-control study. Am J Hypertens. 2008;21:832–5.PubMedCrossRef
99.
Lin SH, Branson C, Leung J, Park L, Doshi N, Auerbach SH. Oximetry as an accurate tool for identifying moderate to severe sleep apnea in patients with acute stroke. J Clin Sleep Med. 2018;14:2065–73.PubMedPubMedCentralCrossRef
100.
Hang L-W, Wang H-L, Chen J-H, Hsu J-C, Lin H-H, Chung W-S, et al. Validation of overnight oximetry to diagnose patients with moderate to severe obstructive sleep apnea. BMC Pulm Med. 2015;15:24.PubMedPubMedCentralCrossRef
101.
da Rosa JCF, Peres A, Gasperin Júnior L, Martinez D, Fontanella V. Diagnostic accuracy of oximetry for obstructive sleep apnea: a study on older adults in a home setting. Clinics (Sao Paulo). 2021;76:e3056.PubMedCrossRef
102.
Aaronson JA, van Bezeij T, van den Aardweg JG, van Bennekom CAM, Hofman WF. Diagnostic accuracy of nocturnal oximetry for detection of sleep apnea syndrome in stroke rehabilitation. Stroke. 2012;43:2491–3.PubMedCrossRef
103.
Álvarez D, Cerezo-Hernández A, Crespo A, Gutiérrez-Tobal GC, Vaquerizo-Villar F, Barroso-García V, et al. A machine learning-based test for adult sleep apnoea screening at home using oximetry and airflow. Sci Rep. 2020;10:5332.ADSPubMedPubMedCentralCrossRef
104.
Borsini EE, Blanco M, Ernst G, Salvado A, Bledel I, Nigro CA. Contribution of pulse oximetry in relation to respiratory flow events in a home-based approach aimed at diagnosing obstructive sleep apnea. Sleep Sci. 2021;14:77–81.PubMedPubMedCentral
105.
Yaddanapudi SS, Pineda MC, Boorman DW, Bryne RE, Hing KL, Sharma S. High-resolution pulse oximetry (HRPO): a cost-effective tool in screening for obstructive sleep apnea (OSA) in acute stroke and predicting outcome. J Stroke Cerebrovasc Dis. 2018;27:2986–92.PubMedCrossRef
106.
Hoppenbrouwer XLR, Fabius T, Eijsvogel M, de Jongh F, Garde A. Airflow from nasal pulse oximetry in the screening of obstructive sleep apnea. Annu Int Conf IEEE Eng Med Biol Soc. 2019;2019:2572–5.PubMed
107.
Linz D, Kadhim K, Brooks AG, Elliott AD, Hendriks JML, Lau DH, et al. Diagnostic accuracy of overnight oximetry for the diagnosis of sleep-disordered breathing in atrial fibrillation patients. Int J Cardiol. 2018;272:155–61.PubMedCrossRef
108.
Chai-Coetzer CL, Antic NA, Rowland LS, Catcheside PG, Esterman A, Reed RL, et al. A simplified model of screening questionnaire and home monitoring for obstructive sleep apnoea in primary care. Thorax. 2011;66:213–9.PubMedCrossRef
109.
Mashaqi S, Staebler D, Mehra R. Combined nocturnal pulse oximetry and questionnaire-based obstructive sleep apnea screening - a cohort study. Sleep Med. 2020;72:157–63.PubMedCrossRef
110.
Bhomra P, Sayeed N, Shah I, Sahal A. Accuracy of overnight pulse oximetry in diagnosing moderate to severe obstructive sleep apnoea. 42 Sleep and Control of Breathing. European Respir Soc. 2016; p. OA4794.
111.
112.
Yamashiro Y, Kryger MH. Nocturnal oximetry: is it a screening tool for sleep disorders? Sleep. 1995;18:167–71.PubMedCrossRef
113.
Chernyshev OY, McCarty DE, Moul DE, Liendo C, Caldito GC, Munjampalli SK, et al. A pilot study: portable out-of-center sleep testing as an early sleep apnea screening tool in acute ischemic stroke. Nat Sci Sleep. 2015;7:127–38.PubMedPubMedCentralCrossRef
114.
Bruyneel M, Sanida C, Art G, Libert W, Cuvelier L, Paesmans M, et al. Sleep efficiency during sleep studies: results of a prospective study comparing home-based and in-hospital polysomnography. J Sleep Res. 2011;20:201–6.PubMedCrossRef
115.
Bruyneel M, Libert W, Ameye L, Ninane V. Comparison between home and hospital set-up for unattended home-based polysomnography: a prospective randomized study. Sleep Med. 2015;16:1434–8.PubMedCrossRef
116.
Saletu MT, Kotzian ST, Schwarzinger A, Haider S, Spatt J, Saletu B. Home sleep apnea testing is a feasible and accurate method to diagnose obstructive sleep apnea in stroke patients during in-hospital rehabilitation. J Clin Sleep Med. 2018;14:1495–501.PubMedPubMedCentralCrossRef
117.
Drager LF, Genta PR, Pedrosa RP, Nerbass FB, Gonzaga CC, Krieger EM, et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol. 2010;105:1135–9.PubMedCrossRef
118.
Srijithesh PR, Shukla G, Srivastav A, Goyal V, Singh S, Behari M. Validity of the Berlin Questionnaire in identifying obstructive sleep apnea syndrome when administered to the informants of stroke patients. J Clin Neurosci. 2011;18:340–3.PubMedCrossRef
119.
Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: Results of a meta-analysis. Arch Intern Med. 2003;163:565–71.PubMedCrossRef
120.
Lin H-J, Yeh J-H, Hsieh M-T, Hsu C-Y. Continuous positive airway pressure with good adherence can reduce risk of stroke in patients with moderate to severe obstructive sleep apnea: an updated systematic review and meta-analysis. Sleep Med Rev. 2020;54:101354.PubMedCrossRef
121.
Hudgel DW, Lamerato LE, Jacobsen GR, Drake CL. Assessment of multiple health risks in a single obstructive sleep apnea population. J Clin Sleep Med. 2012;8:9–18.PubMedPubMedCentralCrossRef
122.
Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med. 2007;176:1274–80.PubMedCrossRef
123.
Capodanno D, Milazzo G, Cumbo M, Marchese A, Salemi A, Quartarone L, et al. Positive airway pressure in patients with coronary artery disease and obstructive sleep apnea syndrome. J Cardiovasc Med (Hagerstown). 2014;15:402–6.PubMedCrossRef
124.
Wuest W, May MS, Wiesmueller M, Uder M, Schmid A. Effect of long term CPAP therapy on cardiac parameters assessed with cardiac MRI. Int J Cardiovasc Imaging. 2021;37:613–21.PubMedCrossRef
125.
Hammerstingl C, Schueler R, Wiesen M, Momcilovic D, Pabst S, Nickenig G, et al. Impact of untreated obstructive sleep apnea on left and right ventricular myocardial function and effects of CPAP therapy. PLoS ONE. 2013;8:e76352.ADSPubMedPubMedCentralCrossRef
126.
Marin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–53.PubMedCrossRef
127.
Guo J, Sun Y, Xue L-J, Huang Z-Y, Wang Y-S, Zhang L, et al. Effect of CPAP therapy on cardiovascular events and mortality in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath. 2016;20:965–74.PubMedCrossRef
128.
Peker Y, Thunström E, Glantz H, Eulenburg C. Effect of obstructive sleep apnea and CPAP treatment on cardiovascular outcomes in acute coronary syndrome in the RICCADSA trial. J Clin Med. 2020;9:4051.PubMedPubMedCentralCrossRef
129.
Huang Z, Liu Z, Luo Q, Zhao Q, Zhao Z, Ma X, et al. Long-term effects of continuous positive airway pressure on blood pressure and prognosis in hypertensive patients with coronary heart disease and obstructive sleep apnea: a randomized controlled trial. Am J Hypertens. 2015;28:300–6.PubMedCrossRef
130.
Myllylä M, Hammais A, Stepanov M, Anttalainen U, Saaresranta T, Laitinen T. Nonfatal and fatal cardiovascular disease events in CPAP compliant obstructive sleep apnea patients. Sleep Breath. 2019;23:1209–17.PubMedPubMedCentralCrossRef
131.
Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62:300–5.PubMedCrossRef
132.
Martínez-García MA, Campos-Rodríguez F, Soler-Cataluña JJ, Catalán-Serra P, Román-Sánchez P, Montserrat JM. Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment. Eur Respir J. 2012;39:906–12.PubMedCrossRef
133.
Bravata DM, Concato J, Fried T, Ranjbar N, Sadarangani T, McClain V, et al. Auto-titrating continuous positive airway pressure for patients with acute transient ischemic attack: a randomized feasibility trial. Stroke. 2010;41:1464–70.PubMedPubMedCentralCrossRef
134.
Blau A, Minx M, Peter JG, Glos M, Penzel T, Baumann G, et al. Auto bi-level pressure relief-PAP is as effective as CPAP in OSA patients–a pilot study. Sleep Breath. 2012;16:773–9.PubMedCrossRef
135.
136.
Steiropoulos P, Kotsianidis I, Nena E, Tsara V, Gounari E, Hatzizisi O, et al. Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep. 2009;32:537–43.PubMedPubMedCentralCrossRef
137.
Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation. 2008;117:2270–8.PubMedPubMedCentralCrossRef
138.
Buchner NJ, Quack I, Stegbauer J, Woznowski M, Kaufmann A, Rump LC. Treatment of obstructive sleep apnea reduces arterial stiffness. Sleep Breath. 2012;16:123–33.PubMedCrossRef
139.
Canessa N, Castronovo V, Cappa SF, Aloia MS, Marelli S, Falini A, et al. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med. 2011;183:1419–26.PubMedCrossRef
140.
Campos-Rodriguez F, Martinez-Garcia MA, Reyes-Nuñez N, Caballero-Martinez I, Catalan-Serra P, Almeida-Gonzalez CV. Role of sleep apnea and continuous positive airway pressure therapy in the incidence of stroke or coronary heart disease in women. Am J Respir Crit Care Med. 2014;189:1544–50.PubMedCrossRef
141.
Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest. 2005;127:2076–84.PubMedCrossRef
142.
Gupta A, Shukla G, Afsar M, Poornima S, Pandey RM, Goyal V, et al. Role of positive airway pressure therapy for obstructive sleep apnea in patients with stroke: a randomized controlled trial. J Clin Sleep Med. 2018;14:511–21.PubMedPubMedCentralCrossRef
143.
Barceló A, Barbé F, de la Peña M, Vila M, Pérez G, Piérola J, et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J. 2006;27:756–60.PubMedCrossRef
144.
Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, Martínez-Alonso M, Carmona C, Barceló A, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307:2161–8.PubMedCrossRef
145.
Thunström E, Manhem K, Rosengren A, Peker Y. Blood pressure response to losartan and continuous positive airway pressure in hypertension and obstructive sleep apnea. Am J Respir Crit Care Med. 2016;193:310–20.PubMedCrossRef
146.
Martínez-García M-A, Capote F, Campos-Rodríguez F, Lloberes P, Díaz de Atauri MJ, Somoza M, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310:2407–15.PubMedCrossRef
147.
Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002;359:204–10.PubMedCrossRef
148.
Gottlieb DJ, Punjabi NM, Mehra R, Patel SR, Quan SF, Babineau DC, et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med. 2014;370:2276–85.PubMedPubMedCentralCrossRef
149.
Barbé F, Durán-Cantolla J, Capote F, de la Peña M, Chiner E, Masa JF, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;181:718–26.PubMedCrossRef
150.
Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012;307:2169–76.PubMedPubMedCentralCrossRef
151.
de Oliveira AC, Martinez D, Massierer D, Gus M, Gonçalves SC, Ghizzoni F, et al. The antihypertensive effect of positive airway pressure on resistant hypertension of patients with obstructive sleep apnea: a randomized, double-blind, clinical trial. Am J Respir Crit Care Med. 2014;190:345–7.PubMedCrossRef
152.
Bernasconi C, Ott SR, Fanfulla F, Miano S, Horvath T, Seiler A, et al. SAS CARE 2 - a randomized study of CPAP in patients with obstructive sleep disordered breathing following ischemic stroke or transient ischemic attack. Sleep Medicine: X. 2020;2:100027.PubMed
153.
Craig SE, Kohler M, Nicoll D, Bratton DJ, Nunn A, Davies R, et al. Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial. Thorax. 2012;67:1090–6.PubMedCrossRef
154.
Sánchez-de-la-Torre M, Sánchez-de-la-Torre A, Bertran S, Abad J, Duran-Cantolla J, Cabriada V, et al. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet Respir Med. 2020;8:359–67.PubMedCrossRef
155.
Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunström E. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. The RICCADSA Randomized Controlled Trial. Am J Respir Crit Care Med. 2016;194:613–20.PubMedCrossRef
156.
Muxfeldt ES, Margallo V, Costa LMS, Guimarães G, Cavalcante AH, Azevedo JCM, et al. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial. Hypertension. 2015;65:736–42.PubMedCrossRef
157.
Phillips CL, McEwen BJ, Morel-Kopp M-C, Yee BJ, Sullivan DR, Ward CM, et al. Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study. Thorax. 2012;67:639–44.PubMedCrossRef
158.
McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375:919–31.PubMedCrossRef
159.
McMillan A, Bratton DJ, Faria R, Laskawiec-Szkonter M, Griffin S, Davies RJ, et al. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial. Lancet Respir Med. 2014;2:804–12.PubMedCrossRef
160.
Bratton DJ, Gaisl T, Schlatzer C, Kohler M. Comparison of the effects of continuous positive airway pressure and mandibular advancement devices on sleepiness in patients with obstructive sleep apnoea: a network meta-analysis. Lancet Respir Med. 2015;3:869–78.PubMedCrossRef
161.
Chin K, Ohi M, Kita H, Noguchi T, Otsuka N, Tsuboi T, et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1996;153:1972–6.PubMedCrossRef
162.
Hollandt JH, Mahlerwein M. Nasal breathing and continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA). Sleep Breath. 2003;7:87–94.PubMedCrossRef
163.
McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159:1108–14.PubMedCrossRef
164.
Wolkove N, Baltzan M, Kamel H, Dabrusin R, Palayew M. Long-term compliance with continuous positive airway pressure in patients with obstructive sleep apnea. Can Respir J. 2008;15:365–9.PubMedPubMedCentralCrossRef
165.
Hsu CY, Vennelle M, Li HY, Engleman HM, Dennis MS, Douglas NJ. Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatr. 2006;77:1143–9.CrossRef
166.
Brown DL, Chervin RD, Kalbfleisch JD, Zupancic MJ, Migda EM, Svatikova A, et al. Sleep apnea treatment after stroke (SATS) trial: is it feasible? J Stroke Cerebrovasc Dis. 2013;22:1216–24.PubMedCrossRef
167.
Martínez-García MA, Galiano-Blancart R, Román-Sánchez P, Soler-Cataluña J-J, Cabero-Salt L, Salcedo-Maiques E. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest. 2005;128:2123–9.PubMedCrossRef
168.
Brown DL, Concannon M, Kaye AB, Zupancic M, Lisabeth LD. Comparison of two headgear systems for sleep apnea treatment of stroke patients. Cerebrovasc Dis. 2009;27:183–6.PubMedCrossRef
169.
Ballard RD, Gay PC, Strollo PJ. Interventions to improve compliance in sleep apnea patients previously non-compliant with continuous positive airway pressure. J Clin Sleep Med. 2007;3:706–12.PubMedPubMedCentralCrossRef
170.
Ramar K, Dort LC, Katz SG, Lettieri CJ, Harrod CG, Thomas SM, et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med. 2015;11:773–827.PubMedPubMedCentralCrossRef
171.
Koretsi V, Eliades T, Papageorgiou SN. Oral interventions for obstructive sleep apnea. Dtsch Arztebl Int. 2018;115:200–7.PubMedPubMedCentral
172.
Hussain SF, Irfan M, Waheed Z, Alam N, Mansoor S, Islam M. Compliance with continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea among privately paying patients- a cross sectional study. BMC Pulm Med. 2014;14:188.PubMedPubMedCentralCrossRef
173.
Palombini L, Guilleminault C. Stroke and treatment with nasal CPAP. Eur J Neurol. 2006;13:198–200.PubMedCrossRef
174.
Hoffstein V, Viner S, Mateika S, Conway J. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis. 1992;145:841–5.PubMedCrossRef
175.
Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep. 1996;19:156–77.PubMedCrossRef
176.
Shah J, Russell JO, Waters T, Kominsky AH, Trask D. Uvulopalatopharyngoplasty vs CN XII stimulation for treatment of obstructive sleep apnea: A single institution experience. Am J Otolaryngol. 2018;39:266–70.PubMedCrossRef
177.
178.
Calik MW, Carley DW. Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats. PLoS ONE. 2014;9:e111412.ADSPubMedPubMedCentralCrossRef
179.
Aaronson JA, Hofman WF, van Bennekom CAM, van Bezeij T, van den Aardweg JG, Groet E, et al. Effects of continuous positive airway pressure on cognitive and functional outcome of stroke patients with obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med. 2016;12:533–41.PubMedPubMedCentralCrossRef
180.
Balcan B, Thunström E, Strollo PJ, Peker Y. Continuous positive airway pressure treatment and depression in adults with coronary artery disease and nonsleepy obstructive sleep apnea. a secondary analysis of the RICCADSA trial. Ann Am Thorac Soc. 2019;16:62–70.PubMedCrossRef
181.
Bravata DM, Concato J, Fried T, Ranjbar N, Sadarangani T, McClain V, et al. Continuous positive airway pressure: evaluation of a novel therapy for patients with acute ischemic stroke. Sleep. 2011;34:1271–7.PubMedPubMedCentralCrossRef
182.
Bravata DM, Sico J, Vaz Fragoso CA, Miech EJ, Matthias MS, Lampert R, et al. Diagnosing and treating sleep apnea in patients with acute cerebrovascular disease. J Am Heart Assoc. 2018;7:e008841.PubMedPubMedCentralCrossRef
183.
Celik Y, Thunström E, Strollo PJ, Peker Y. Continuous positive airway pressure treatment and anxiety in adults with coronary artery disease and nonsleepy obstructive sleep apnea in the RICCADSA trial. Sleep Med. 2021;77:96–103.PubMedCrossRef
184.
Drager LF, Tavoni TM, Silva VM, Santos RD, Pedrosa RP, Bortolotto LA, et al. Obstructive sleep apnea and effects of CPAP on triglyceride-rich lipoprotein metabolism. J Lipid Res. 2018;59:1027–33
185.
Martínez-García MA, Soler-Cataluña JJ, Ejarque-Martínez L, Soriano Y, Román-Sánchez P, Illa FB, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med. 2009;180:36–41.PubMedCrossRef
186.
Minnerup J, Ritter MA, Wersching H, Kemmling A, Okegwo A, Schmidt A, et al. Continuous positive airway pressure ventilation for acute ischemic stroke: a randomized feasibility study. Stroke. 2012;43:1137–9.PubMedCrossRef
187.
Oliveira W, Campos O, Cintra F, Matos L, Vieira MLC, Rollim B, et al. Impact of continuous positive airway pressure treatment on left atrial volume and function in patients with obstructive sleep apnoea assessed by real-time three-dimensional echocardiography. Heart. 2009;95:1872–8.PubMedCrossRef
188.
Parra O, Sánchez-Armengol A, Bonnin M, Arboix A, Campos-Rodríguez F, Pérez-Ronchel J, et al. Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial. Eur Respir J. 2011;37:1128–36.PubMedCrossRef
189.
Parra O, Sánchez-Armengol Á, Capote F, Bonnin M, Arboix A, Campos-Rodríguez F, et al. Efficacy of continuous positive airway pressure treatment on 5-year survival in patients with ischaemic stroke and obstructive sleep apnea: a randomized controlled trial. J Sleep Res. 2015;24:47–53.PubMedCrossRef
190.
Khot SP, Davis AP, Crane DA, Tanzi PM, Lue DL, Claflin ES, et al. Effect of continuous positive airway pressure on stroke rehabilitation: a pilot randomized sham-controlled trial. J Clin Sleep Med. 2016;12:1019–26.PubMedPubMedCentralCrossRef
191.
Ryan CM, Bayley M, Green R, Murray BJ, Bradley TD. Influence of continuous positive airway pressure on outcomes of rehabilitation in stroke patients with obstructive sleep apnea. Stroke. 2011;42:1062–7.PubMedCrossRef
192.
Sandberg O, Franklin KA, Bucht G, Eriksson S, Gustafson Y. Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J. 2001;18:630–4.PubMedCrossRef
193.
Scala R, Turkington PM, Wanklyn P, Bamford J, Elliott MW. Acceptance, effectiveness and safety of continuous positive airway pressure in acute stroke: a pilot study. Respir Med. 2009;103:59–66.PubMedCrossRef
194.
Yaranov DM, Smyrlis A, Usatii N, Butler A, Petrini JR, Mendez J, et al. Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation. Am J Cardiol. 2015;115:461–5.PubMedCrossRef
195.
Lamberts M, Nielsen OW, Lip GYH, Ruwald MH, Christiansen CB, Kristensen SL, et al. Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults. J Intern Med. 2014;276:659–66.PubMedCrossRef
196.
Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19–25.PubMedCrossRef
197.
Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005;172:1447–51.PubMedPubMedCentralCrossRef
198.
Bassetti CL, Milanova M, Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke. 2006;37:967–72.PubMedCrossRef
199.
Ahn SH, Kim JH, Kim DU, Choo IS, Lee HJ, Kim HW. Interaction between sleep-disordered breathing and acute ischemic stroke. J Clin Neurol. 2013;9:9–13.PubMedPubMedCentralCrossRef
200.
Mansukhani MP, Bellolio MF, Kolla BP, Enduri S, Somers VK, Stead LG. Worse outcome after stroke in patients with obstructive sleep apnea: an observational cohort study. J Stroke Cerebrovasc Dis. 2011;20:401–5.PubMedCrossRef
201.
Munoz R, Duran-Cantolla J, Martínez-Vila E, Gallego J, Rubio R, Aizpuru F, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke. 2006;37:2317–21.PubMedCrossRef
202.
Marshall NS, Wong KKH, Cullen SRJ, Knuiman MW, Grunstein RR. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med. 2014;10:355–62.PubMedPubMedCentralCrossRef
203.
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–41.PubMedCrossRef
204.
Rice TB, Foster GD, Sanders MH, Unruh M, Reboussin D, Kuna ST, et al. The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus. Sleep. 2012;35:1293–8.PubMedPubMedCentralCrossRef
205.
Mohsenin V, Valor R. Sleep apnea in patients with hemispheric stroke. Arch Phys Med Rehabil. 1995;76:71–6.PubMedCrossRef
206.
Molnar MZ, Mucsi I, Novak M, Szabo Z, Freire AX, Huch KM, et al. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax. 2015;70:888–95.PubMedCrossRef
207.
Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation. 2008;118:955–60.PubMedCrossRef
208.
209.
210.
Chang C-C, Chuang H-C, Lin C-L, Sung F-C, Chang Y-J, Hsu CY, et al. High incidence of stroke in young women with sleep apnea syndrome. Sleep Med. 2014;15:410–4.PubMedCrossRef
211.
Šiarnik P, Kollár B, Čarnická Z, Šurda P, Klobučníková K, Sýkora M, et al. Association of sleep disordered breathing with wake-up acute ischemic stroke: a full polysomnographic study. J Clin Sleep Med. 2016;12:549–54.PubMedPubMedCentralCrossRef
212.
Brown DL, Shafie-Khorassani F, Kim S, Chervin RD, Case E, Morgenstern LB, et al. Sleep-disordered breathing is associated with recurrent ischemic stroke. Stroke. 2019;50:571–6.PubMedPubMedCentralCrossRef
213.
Dyken ME, Somers VK, Yamada T, Ren ZY, Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke. 1996;27:401–7.PubMedCrossRef
214.
Bassetti C, Aldrich MS, Chervin RD, Quint D. Sleep apnea in patients with transient ischemic attack and stroke: a prospective study of 59 patients. Neurology. 1996;47:1167–73.PubMedCrossRef
215.
Noradina AT, Hamidon BB, Roslan H, Raymond AA. Risk factors for developing sleep-disordered breathing in patients with recent ischaemic stroke. Singapore Med J. 2006;47:392–9.PubMed
216.
Wessendorf TE, Teschler H, Wang YM, Konietzko N, Thilmann AF. Sleep-disordered breathing among patients with first-ever stroke. J Neurol. 2000;247:41–7.PubMedCrossRef
217.
Pearce DC, Cadilhac DA, Pierce RJ, Thrift AG, David S, Donnan GA, et al. Estimating the prevalence of sleep-disordered breathing in community-based, long-term stroke survivors using a validated predictive model. Cerebrovasc Dis. 2008;26:441–6.PubMedCrossRef
218.
Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O’Connor GT, Resnick HE, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med. 2010;182:269–77.PubMedPubMedCentralCrossRef
219.
Yan-fang S, Yu-ping W. Sleep-disordered breathing: impact on functional outcome of ischemic stroke patients. Sleep Med. 2009;10:717–9.PubMedCrossRef
220.
Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med. 2008;168:297–301.PubMedCrossRef
221.
Kumar R, Suri JC, Manocha R. Study of association of severity of sleep disordered breathing and functional outcome in stroke patients. Sleep Med. 2017;34:50–6.PubMedCrossRef
222.
Menon D, Sukumaran S, Varma R, Radhakrishnan A. Impact of obstructive sleep apnea on neurological recovery after ischemic stroke: a prospective study. Acta Neurol Scand. 2017;136:419–26.PubMedCrossRef
223.
Turkington PM, Allgar V, Bamford J, Wanklyn P, Elliott MW. Effect of upper airway obstruction in acute stroke on functional outcome at 6 months. Thorax. 2004;59:367–71.PubMedPubMedCentralCrossRef
224.
Arzt M, Young T, Peppard PE, Finn L, Ryan CM, Bayley M, et al. Dissociation of obstructive sleep apnea from hypersomnolence and obesity in patients with stroke. Stroke. 2010;41:e129–34.PubMedPubMedCentralCrossRef
225.
Lisabeth LD, Sánchez BN, Lim D, Chervin RD, Case E, Morgenstern LB, et al. Sleep-disordered breathing and poststroke outcomes. Ann Neurol. 2019;86:241–50.PubMedPubMedCentralCrossRef
226.
Good DC, Henkle JQ, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke. 1996;27:252–9.PubMedCrossRef
227.
Aaronson JA, van Bennekom CAM, Hofman WF, van Bezeij T, van den Aardweg JG, Groet E, et al. Obstructive sleep apnea is related to impaired cognitive and functional status after stroke. Sleep. 2015;38:1431–7.PubMedPubMedCentralCrossRef
228.
Kaneko Y, Hajek VE, Zivanovic V, Raboud J, Bradley TD. Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep. 2003;26:293–7.PubMedCrossRef
229.
Broadley SA, Jørgensen L, Cheek A, Salonikis S, Taylor J, Thompson PD, et al. Early investigation and treatment of obstructive sleep apnoea after acute stroke. J Clin Neurosci. 2007;14:328–33.PubMedCrossRef
230.
Brown DL, McDermott M, Mowla A, De Lott L, Morgenstern LB, Kerber KA, et al. Brainstem infarction and sleep-disordered breathing in the BASIC sleep apnea study. Sleep Med. 2014;15:887–91.PubMedPubMedCentralCrossRef
231.
Cadilhac DA, Thorpe RD, Pearce DC, Barnes M, Rochford PD, Tarquinio N, et al. Sleep disordered breathing in chronic stroke survivors. A study of the long term follow-up of the SCOPES cohort using home based polysomnography. J Clin Neurosci. 2005;12:632–7.PubMedCrossRef
232.
Davies DP, Rodgers H, Walshaw D, James OFW, Gibson GJ. Snoring, daytime sleepiness and stroke: a case-control study of first-ever stroke. J Sleep Res. 2003;12:313–8.PubMedCrossRef
233.
Elwood P, Hack M, Pickering J, Hughes J, Gallacher J. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health. 2006;60:69–73.PubMedPubMedCentralCrossRef
234.
Hsieh S-W, Lai C-L, Liu C-K, Hsieh C-F, Hsu C-Y. Obstructive sleep apnea linked to wake-up strokes. J Neurol. 2012;259:1433–9.PubMedCrossRef
235.
Lipford MC, Flemming KD, Calvin AD, Mandrekar J, Brown RD, Somers VK, et al. Associations between cardioembolic stroke and obstructive sleep apnea. Sleep. 2015;38:1699–705.PubMedPubMedCentralCrossRef
236.
Parra O, Arboix A, Bechich S, García-Eroles L, Montserrat JM, López JA, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med. 2000;161:375–80.PubMedCrossRef
237.
Väyrynen K, Kortelainen K, Numminen H, Miettinen K, Keso A, Tenhunen M, et al. Screening sleep disordered breathing in stroke unit. Sleep Disord. 2014;2014:317615.PubMedPubMedCentralCrossRef
238.
Xie W, Zheng F, Song X. Obstructive sleep apnea and serious adverse outcomes in patients with cardiovascular or cerebrovascular disease: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2014;93:e336.PubMedCrossRef
239.
Zhang Y, Wang W, Cai S, Sheng Q, Pan S, Shen F, et al. Obstructive sleep apnea exaggerates cognitive dysfunction in stroke patients. Sleep Med. 2017;33:183–90.PubMedCrossRef
240.
Palomäki H, Partinen M, Juvela S, Kaste M. Snoring as a risk factor for sleep-related brain infarction. Stroke. 1989;20:1311–5.PubMedCrossRef
241.
242.
KoskenvuoKaptrio M, Kaprio J, Telakivii T, Partinen M, Heikkila K, Sarna S, et al. Snoring as a risk factor for ischaemic heart disease and stroke in men. Br Med J. 1987;294:16–9.CrossRef
243.
Wang Y, Guo SZ, Bonen A, Li RC, Kheirandish-Gozal L, Zhang SXL, et al. Monocarboxylate transporter 2 and stroke severity in a rodent model of sleep apnea. J Neurosci. 2011;31:10241–8.PubMedPubMedCentralCrossRef
244.
245.
Nobili L, Schiavi G, Bozano E, De Carli F, Ferrillo F, Nobili F. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc. 2000;22:21–7.PubMed
246.
Franco CMR, Lima AMJ, Ataíde L, Lins OG, Castro CMM, Bezerra AA, et al. Obstructive sleep apnea severity correlates with cellular and plasma oxidative stress parameters and affective symptoms. J Mol Neurosci. 2012;47:300–10.PubMedCrossRef
247.
Vatansever E, Surmen-Gur E, Ursavas A, Karadag M. Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath. 2011;15:275–82.PubMedCrossRef
248.
Ogihara T, Hirano K, Ogihara H, Misaki K, Hiroi M, Morinobu T, et al. Non-protein-bound transition metals and hydroxyl radical generation in cerebrospinal fluid of newborn infants with hypoxic ischemic encephalopathy. Pediatr Res. 2003;53:594–9.PubMedCrossRef
249.
Tsai N-W, Chang Y-T, Huang C-R, Lin Y-J, Lin W-C, Cheng B-C, et al. Association between oxidative stress and outcome in different subtypes of acute ischemic stroke. Biomed Res Int. 2014;2014:256879.PubMedPubMedCentralCrossRef
250.
Bassetti CLA. Sleep and stroke: A bidirectional relationship with clinical implications. Sleep Med Rev. 2019;45:127–8.PubMedCrossRef
251.
Duss SB, Brill A-K, Bargiotas P, Facchin L, Alexiev F, Manconi M, et al. Sleep-wake disorders in stroke-increased stroke risk and deteriorated recovery? An evaluation on the necessity for prevention and treatment. Curr Neurol Neurosci Rep. 2018;18:1–15.CrossRef
252.
Javaheri S, Peker Y, Yaggi HK, Bassetti CLA. Obstructive sleep apnea and stroke: The mechanisms, the randomized trials, and the road ahead. Sleep Med Rev. 2022;61:101568.PubMedCrossRef
253.
Kimura K, Yamashita S, Shibazaki K. Cardioembolic stroke associated with atrial fibrillation. Rinsho Shinkeigaku. 2013;53:989–91.PubMedCrossRef
254.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-292.PubMed
255.
Todd K, McIntyre WF, Baranchuk A. Obstructive sleep apnea and atrial fibrillation. Nat Sci Sleep. 2010;2:39–45.PubMedPubMedCentral
256.
Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery–-executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002;105:1257–67.PubMedCrossRef
257.
Lin C-C, Keller JJ, Kang J-H, Hsu T-C, Lin H-C. Obstructive sleep apnea is associated with an increased risk of venous thromboembolism. J Vasc Surg Venous Lymphat Disord. 2013;1:139–45.PubMedCrossRef
258.
Shah YM, Xie L. Hypoxia-inducible factors link iron homeostasis and erythropoiesis. Gastroenterology. 2014;146:630–42.PubMedCrossRef
259.
Chen M, Wu B, Ye X, Zhou Z, Yue X, Wang Q, et al. Association between plasma homocysteine levels and obstructive sleep apnoea in patients with ischaemic stroke. J Clin Neurosci. 2011;18:1454–7.PubMedCrossRef
260.
Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3:1894–904.PubMedCrossRef
261.
Zamarrón-Sanz C, Ricoy-Galbaldon J, Gude-Sampedro F, Riveiro-Riveiro A. Plasma levels of vascular endothelial markers in obstructive sleep apnea. Arch Med Res. 2006;37:552–5.PubMedCrossRef
262.
Wessendorf TE, Thilmann AF, Wang YM, Schreiber A, Konietzko N, Teschler H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med. 2000;162:2039–42.PubMedCrossRef
263.
Belch J, McLaren M, Hanslip J, Hill A, Davidson D. The white blood cell and plasma fibrinogen in thrombotic stroke A significant correlation. Int Angiol. 1998;17:120–4.PubMed
264.
von Känel R, Malan NT, Hamer M, Lambert GW, Schlaich M, Reimann M, et al. Three-year changes of prothrombotic factors in a cohort of South Africans with a high clinical suspicion of obstructive sleep apnea. Thromb Haemost. 2016;115:63–72.CrossRef
265.
Robinson GV, Pepperell JCT, Segal HC, Davies RJO, Stradling JR. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax. 2004;59:777–82.PubMedPubMedCentralCrossRef
266.
Peled N, Kassirer M, Kramer MR, Rogowski O, Shlomi D, Fox B, et al. Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. Thromb Res. 2008;121:631–6.PubMedCrossRef
267.
Lavie L, Dyugovskaya L, Lavie P. Sleep-apnea-related intermittent hypoxia and atherogenesis: adhesion molecules and monocytes/endothelial cells interactions. Atherosclerosis. 2005;183:183–4.PubMedCrossRef
268.
Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor PH, et al. Vascular inflammation in obesity and sleep apnea. Circulation. 2010;121:1014–21.PubMedPubMedCentralCrossRef
269.
Chen C-Y, Chen C-L, Yu C-C, Chen T-T, Tseng S-T, Ho C-H. Association of inflammation and oxidative stress with obstructive sleep apnea in ischemic stroke patients. Sleep Med. 2015;16:113–8.PubMedCrossRef
270.
van Leeuwen WMA, Lehto M, Karisola P, Lindholm H, Luukkonen R, Sallinen M, et al. Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS ONE. 2009;4:e4589.ADSPubMedPubMedCentralCrossRef
271.
Medeiros CAM, de Bruin VMS, Andrade GM, Coutinho WM, de Castro-Silva C, de Bruin PFC. Obstructive sleep apnea and biomarkers of inflammation in ischemic stroke. Acta Neurol Scand. 2012;126:17–22.PubMedCrossRef
272.
Ifergane G, Ovanyan A, Toledano R, Goldbart A, Abu-Salame I, Tal A, et al. Obstructive sleep apnea in acute stroke: a role for systemic inflammation. Stroke. 2016;47:1207–12.PubMedCrossRef
273.
Shamsuzzaman ASM, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105:2462–4.PubMedCrossRef
274.
Andaku DK, D’Almeida V, Carneiro G, Hix S, Tufik S, Togeiro SM. Sleepiness, inflammation and oxidative stress markers in middle-aged males with obstructive sleep apnea without metabolic syndrome: a cross-sectional study. Respir Res. 2015;16:3.PubMedPubMedCentralCrossRef
275.
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327–34.PubMedCrossRef
276.
Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA. 2003;290:2945–51.PubMedCrossRef
277.
278.
Dziewas R, Ritter M, Usta N, Boentert M, Hor H, Dittrich R, et al. Atherosclerosis and obstructive sleep apnea in patients with ischemic stroke. Cerebrovasc Dis. 2007;24:122–6.PubMedCrossRef
279.
Nachtmann A, Stang A, Wang Y-M, Wondzinski E, Thilmann AF. Association of obstructive sleep apnea and stenotic artery disease in ischemic stroke patients. Atherosclerosis. 2003;169:301–7.PubMedCrossRef
280.
Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2005;172:613–8.PubMedCrossRef
281.
Eisensehr I, Ehrenberg BL, Noachtar S, Korbett K, Byrne A, McAuley A, et al. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology. 1998;51:188–95.PubMedCrossRef
282.
Fleming WE, Holty J-EC, Bogan RK, Hwang D, Ferouz-Colborn AS, Budhiraja R, et al. Use of blood biomarkers to screen for obstructive sleep apnea. Nat Sci Sleep. 2018;10:159–67.PubMedPubMedCentralCrossRef
283.
Gotoh S, Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, et al. Hematocrit and the risk of cardiovascular disease in a Japanese community: the Hisayama Study. Atherosclerosis. 2015;242:199–204.PubMedCrossRef
284.
Swarowska M, Polczak A, Pera J, Klimkowicz-Mrowiec A, Slowik A, Dziedzic T. Hyperfibrinogenemia predicts long-term risk of death after ischemic stroke. J Thromb Thrombolysis. 2014;38:517–21.PubMedPubMedCentralCrossRef
285.
Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 1987;92:181–7.PubMedPubMedCentralCrossRef
286.
Verma S, Anderson TJ. The ten most commonly asked questions about endothelial function in cardiology. Cardiol Rev. 2001;9:250–2.PubMedCrossRef
287.
Förstermann U, Mügge A, Alheid U, Haverich A, Frölich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res. 1988;62:185–90.PubMedCrossRef
288.
Hadi HAR, Carr CS, Al SJ. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag. 2005;1:183–98.PubMedPubMedCentral
289.
Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1996;93:13176–81.ADSPubMedPubMedCentralCrossRef
290.
Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, Maeda N. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest. 2000;105:451–8.PubMedPubMedCentralCrossRef
291.
Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001;104:448–54.PubMedCrossRef
292.
Song T-J, Park J-H, Choi KH, Kim J-H, Choi Y, Chang Y, et al. Is obstructive sleep apnea associated with the presence of intracranial cerebral atherosclerosis? Sleep Breath. 2017;21:639–46.PubMedCrossRef
293.
Nagahama H, Soejima M, Uenomachi H, Higashi Y, Yotsumoto K, Samukawa T, et al. Pulse wave velocity as an indicator of atherosclerosis in obstructive sleep apnea syndrome patients. Intern Med. 2004;43:184–8.PubMedCrossRef
294.
Karkinski D, Georgievski O, Dzekova-Vidimliski P, Milenkovic T, Dokic D. Obstructive sleep apnea and lipid abnormalities. Open Access Maced J Med Sci. 2017;5:19–22.PubMedPubMedCentralCrossRef
295.
Jia S, Zhou Y-J, Yu Y, Wu S-J, Sun Y, Wang Z-J, et al. Obstructive sleep apnea is associated with severity and long-term prognosis of acute coronary syndrome. J Geriatr Cardiol. 2018;15:146–52.PubMedPubMedCentral
296.
Gottlieb DJ, Yenokyan G, Newman AB, O’Connor GT, Punjabi NM, Quan SF, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122:352–60.PubMedPubMedCentralCrossRef
297.
Chen C-Y, Chen C-L, Yu C-C. Obstructive sleep apnea is independently associated with arterial stiffness in ischemic stroke patients. J Neurol. 2015;262:1247–54.PubMedCrossRef
298.
Cereda CW, Tamisier R, Manconi M, Andreotti J, Frangi J, Pifferini V, et al. Endothelial dysfunction and arterial stiffness in ischemic stroke: the role of sleep-disordered breathing. Stroke. 2013;44:1175–8.PubMedCrossRef
299.
Sakuragi S, Abhayaratna K, Gravenmaker KJ, O’Reilly C, Srikusalanukul W, Budge MM, et al. Influence of adiposity and physical activity on arterial stiffness in healthy children: the lifestyle of our kids study. Hypertension. 2009;53:611–6.PubMedCrossRef
300.
Singer J, Trollor JN, Baune BT, Sachdev PS, Smith E. Arterial stiffness, the brain and cognition: a systematic review. Ageing Res Rev. 2014;15:16–27.PubMedCrossRef
301.
Wu W-T, Tsai S-S, Shih T-S, Lin M-H, Chou T-C, Ting H, et al. The association between obstructive sleep apnea and metabolic markers and lipid profiles. PLoS ONE. 2015;10:e0130279.PubMedPubMedCentralCrossRef
302.
Gündüz C, Basoglu OK, Hedner J, Zou D, Bonsignore MR, Hein H, et al. Obstructive sleep apnoea independently predicts lipid levels: data from the European Sleep Apnea Database. Respirology. 2018;23:1180–9.PubMedCrossRef
303.
Pawar NH, O’Riordan JA, Malik P, Vasanwala FF. Obstructive sleep apnea: an unusual cause of hemorrhagic stroke. Cureus. 2017;9:e1718.PubMedPubMedCentral
304.
Zaremba S, Albus L, Schuss P, Vatter H, Klockgether T, Güresir E. Increased risk for subarachnoid hemorrhage in patients with sleep apnea. J Neurol. 2019;266:1351–7.PubMedCrossRef
305.
Geer JH, Falcone GJ, Vanent KN, Leasure AC, Woo D, Molano JR, et al. Obstructive sleep apnea as a risk factor for intracerebral hemorrhage. Stroke. 2021;52:1835–8.PubMedPubMedCentralCrossRef
306.
307.
Woo D, Haverbusch M, Sekar P, Kissela B, Khoury J, Schneider A, et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke. 2004;35:1703–8.PubMedCrossRef
308.
Harbison J, Ford GA, James OFW, Gibson GJ. Sleep-disordered breathing following acute stroke. QJM. 2002;95:741–7.PubMedCrossRef
309.
310.
McCurry SM, Zhu W, Von Korff M, Wellman R, Morin CM, Thakral M, et al. Effect of telephone cognitive behavioral therapy for insomnia in older adults with osteoarthritis pain: A randomized clinical trial. JAMA Intern Med. 2021;181:530–8.PubMedCrossRef
311.
Mason M, Cates CJ, Smith I. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2015;CD011090.
312.
Carter SG, Carberry JC, Cho G, Fisher LP, Rollo CM, Stevens DJ, et al. Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial. Eur Respir J. 2018;52(6):1800149.
313.
Lettieri CJ, Shah AA, Holley AB, Kelly WF, Chang AS, Roop SA, et al. Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial. Ann Intern Med. 2009;151:696–702.PubMedCrossRef
314.
Lettieri CJ, Quast TN, Eliasson AH, Andrada T. Eszopiclone improves overnight polysomnography and continuous positive airway pressure titration: a prospective, randomized, placebo-controlled trial. Sleep. 2008;31:1310–6.PubMedPubMedCentral
315.
Dauvilliers Y, Zammit G, Fietze I, Mayleben D, Seboek Kinter D, Pain S, et al. Daridorexant, a new dual orexin receptor antagonist to treat insomnia disorder. Ann Neurol. 2020;87:347–56.PubMedCrossRef
316.
Do D. Trends in the use of medications with insomnia side effects and the implications for insomnia among US adults. J Sleep Res. 2020;29:e13075.PubMedCrossRef
317.
Jiménez JA, Greenberg BH, Mills PJ. Effects of heart failure and its pharmacological management on sleep. Drug Discov Today Dis Models. 2011;8:161–6.PubMedPubMedCentralCrossRef
318.
Segù M, Cosi A, Santagostini A, Scribante A. Efficacy of a trial oral appliance in OSAS management: A new protocol to recognize responder/nonresponder patients. Int J Dent. 2021;2021:8811700.PubMedPubMedCentralCrossRef
319.
Schramm P, Das N, Schneiderman E, German Z, Hui J, Wilson D, et al. Snoring remediation with oral appliance therapy potentially reverses cognitive impairment: an intervention controlled pilot study. Geriatrics (Basel). 2021;6:107.PubMedCrossRef
320.
Brellenthin AG, Lee D. Abstract 038: comparative effects of aerobic, resistance, and combined exercise on sleep. Circulation. 2022;145.
321.
West DWD, Kujbida GW, Moore DR, Atherton P, Burd NA, Padzik JP, et al. Resistance exercise-induced increases in putative anabolic hormones do not enhance muscle protein synthesis or intracellular signalling in young men. J Physiol (Lond). 2009;587:5239–47.PubMedCrossRef
322.
Kraemer WJ, Ratamess NA. Hormonal responses and adaptations to resistance exercise and training. Sports Med. 2005;35:339–61.PubMedCrossRef
323.
324.
325.
Wesselius HM, van den Ende ES, Alsma J, Ter Maaten JC, Schuit SCE, Stassen PM, et al. Quality and quantity of sleep and factors associated with sleep disturbance in hospitalized patients. JAMA Intern Med. 2018;178:1201–8.PubMedPubMedCentralCrossRef
326.
Gathecha E, Rios R, Buenaver LF, Landis R, Howell E, Wright S. Pilot study aiming to support sleep quality and duration during hospitalizations. J Hosp Med. 2016;11:467–72.PubMedCrossRef
327.
Hajjar RR. Sleep disturbance in palliative care. Clin Geriatr Med. 2008;24:83–91, vii.
328.
Cho YW, Kim KT, Moon H-J, Korostyshevskiy VR, Motamedi GK, Yang KI. Comorbid insomnia with obstructive sleep apnea: clinical characteristics and risk factors. J Clin Sleep Med. 2018;14:409–17.PubMedPubMedCentralCrossRef
329.
Zhang Y, Ren R, Lei F, Zhou J, Zhang J, Wing Y-K, et al. Worldwide and regional prevalence rates of co-occurrence of insomnia and insomnia symptoms with obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med Rev. 2019;45:1–17.PubMedCrossRef
330.
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52:e364-467.PubMedCrossRef
Metadaten
Titel
Obstructive Sleep Apnea and Stroke: Determining the Mechanisms Behind their Association and Treatment Options
verfasst von
Basma Mohamed
Keerthi Yarlagadda
Zachary Self
Alexandra Simon
Frank Rigueiro
Maryam Sohooli
Stephan Eisenschenk
Sylvain Doré
Publikationsdatum
16.03.2023
Verlag
Springer US
Erschienen in
Translational Stroke Research / Ausgabe 2/2024
Print ISSN: 1868-4483
Elektronische ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-023-01123-x

Weitere Artikel der Ausgabe 2/2024

Translational Stroke Research 2/2024 Zur Ausgabe

Research

Exercise Improves Cerebral Blood Flow and Functional Outcomes in an Experimental Mouse Model of Vascular Cognitive Impairment and Dementia (VCID)

Comment

Intracranial Pressure Monitoring: an Effective Technique to Balance Cerebral Perfusion and Blood Pressure Reduction in ICH Patients

Research

Targeted Metabolomic Biomarkers for Stroke Subtyping

Research

Serum Interleukin-1 Levels Are Associated with Intracranial Aneurysm Instability

Research

Anti-Apoptotic Effects of AMPA Receptor Antagonist Perampanel in Early Brain Injury After Subarachnoid Hemorrhage in Mice

Research

Comprehensive CCM3 Mutational Analysis in Two Patients with Syndromic Cerebral Cavernous Malformation

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 | Parkinson-Krankheit | Podcast | Nachrichten

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus
Professorin Dr. Claudia Trenkwalder, Neurologin

22.04.2024 | DGIM 2024 | Nachrichten

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

19.04.2024 | AAN-Jahrestagung 2024 | Nachrichten

Hustenstiller lindert Agitation bei Alzheimer
weitere anzeigen

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise